Liquiritin attenuates advanced glycation end products-induced endothelial dysfunction via RAGE/NF-κB pathway in human umbilical vein endothelial cells

Molecular and Cellular Biochemistry

Volumn 374, Issue 1-2, 2013, Pages 191-201

  Zhang, Xiaoyi ^a   Song, Yu ^a   Han, Xiaolin ^a   Feng, Liang ^b   Wang, Rushang ^c   Zhang, Minghua ^b   Zhu, Maomao ^d   Jia, Xiaobin ^b   Hu, Shaoying ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

^c Institute of Conson Co for Chinese Medicine in Kidiney Diseases   (China)

^d Analysis Center of Rudong County Grain Bureau   (China)

Author keywords

Advanced glycation end products; Diabetes; Endothelial dysfunction; Liquiritin; RAGE NF B pathway

Indexed keywords

ACRIDINE ORANGE; ADVANCED GLYCATION END PRODUCT; ETHIDIUM BROMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIQUIRITIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; APOPTOSIS; CORONARY ARTERY DISEASE; DOWN-REGULATION; FLAVANONES; GLUCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; HERBAL MEDICINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALONDIALDEHYDE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84871967742     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1519-0     Document Type: Article

References (41)

1. Klempfner R, Leor J, Tenenbaum A, Fisman EZ, Goldenberg I (2012) Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease. Cardiovasc Diabetol 11:60
2. Li FY, Lam KS, Tse HF, Chen C, Wang Y, Vanhoutte PM, Xu A (2012) Endothelium-selective activation of AMP-activated protein kinase prevents diabetes-induced impairment in vascular function and re-endothelialization via induction of heme oxygenase-1 in mice. Circulation. doi: 10.1161/CIRCULATIONAHA. 112.108159
3. Fels J, Jeggle P, Kusche-Vihrog K, Oberleithner H (2012) Cortical actin nanodynamics determines nitric oxide release in vascular endothelium. PLoS ONE 7:e41520
4. Karaman A, Bayram F, Gundogan K, Ozsan M, Karaman H, Kelestimur F (2012) Prevalence of diabetes mellitus and glucose metabolism disorders in the first degree relatives of type 2 diabetic patients. Bratisl Lek Listy 113:361-367
5. Takeuchi M, Iwaki M, Takino J, Shirai H, Kawakami M, Bucala R, Yamagishi S (2010) Immunological detection of fructose-derived advanced glycation end-products. Lab Invest 90:1117-1127
6. Jiang J, Chen P, Chen J, Yu X, Xie D, Mei C, Xiong F, Shi W, Zhou W, Liu X, Sun S, Zhang P, Yang X, Zhang Y, Zhang Y, Liang X, Zhang Z, Lin Q, Yu Y, Miyata T, Tian J, Liang M, Luo W, Xu X, Hou F (2012) Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis. Atherosclerosis. doi: 10.1016/j.atherosclerosis.2012.06.022
7. Ojima A, Matsui T, Maeda S, Takeuchi M, Yamagishi S (2012) Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties. Horm Metab Res 44:501-505
8. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810-17814
9. Sun YX, Tang Y, Wu AL, Liu T, Dai XL, Zheng QS, Wang ZB (2010) Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties. J Asian Nat Prod Res 12:1051-1060
10. Zhao Z, Wang W, Guo H, Zhou D (2008) Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats. Behav Brain Res 194:108-113
11. Ko BS, Jang JS, Hong SM, Sung SR, Lee JE, Lee MY, Jeon WK, Park S (2007) Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch, modify insulin sensitizing and insulinotropic actions. Biosci Biotechnol Biochem 71:1452-1461
12. Franke S, Sommer M, Rüster C, Bondeva T, Marticke J, Hofmann G, Hein G, Wolf G (2009) Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells. Arthritis Res Ther 11:R136
13. Xu Y, Feng L, Wang S, Zhu Q, Zheng Z, Xiang P, He B, Tang D (2011) Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration. J Ethnopharmacol 137:359-370
14. Maeda S, Matsui T, Takeuchi M, Yoshida Y, Yamakawa R, Fukami K, Yamagishi S (2011) Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis. Pharmacol Res 63:241-248
15. Xu Y, Feng L, Wang S, Zhu Q, Lin J, Lou C, Xiang P, He B, Zheng Z, Tang D, Zuo G (2011) Phytoestrogen calycosin-7-O-β-d-glucopyranoside ameliorates advanced glycation end products-induced HUVEC damage. J Cell Biochem 112:2953-2965
16. Preethy CP, Padmapriya R, Periasamy VS, Riyasdeen A, Srinag S, Krishnamurthy H, Alshatwi AA, Akbarsha MA (2012) Antiproliferative property of n-hexane and chloroform extracts of Anisomeles malabarica (L). R. Br. in HPV16-positive human cervical cancer cells. J Pharmacol Pharmacother 3:26-34
17. Torreggiani M, Liu H, Wu J, Zheng F, Cai W, Striker G, Vlassara H (2009) Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. Am J Pathol 175:1722-1732
18. Wagener FA, Dekker D, Berden JH, Scharstuhl A, van der Vlag J (2009) The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis 14:1451-1458
19. Lee EY, Lee MY, Hong SW, Chung CH, Hong SY (2007) Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats. Yonsei Med J 48:847-855
20. Untergasser G, Gander R, Rumpold H, Heinrich E, Plas E, Berger P (2003) TGF-beta cytokines increase senescence-associated beta-galactosidase activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence. Exp Gerontol 38:1179-1188
21. Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, Zhang X (2008) Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal 10:1699-1712
22. Yu S, Li H, Ma Y, Fu Y (2012) Matrix metalloproteinase-1 of gingival fibroblasts influenced by advanced glycation end products (AGEs) and their association with receptor for AGEs and nuclear factor-κB in gingival connective tissue. J Periodontol 83:119-126
23. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009) Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 157:527-536
24. Kinlay S, Libby P, Ganz P (2001) Endothelial function and coronary artery disease. Curr Opin Lipidol 12:383-389
25. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Lüscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ, Working group on endothelins and endothelial factors of the European society of hypertension (2005) Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertension. J Hypertens 23:233-246
26. Han SH, Kim YH, Mook-Jung I (2011) RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells 31:91-97
27. Zhou X, Wang B, Zhu L, Hao S (2012) A novel improved therapy strategy for diabetic nephropathy: targeting AGEs. Organogenesis 8:18-21
28. Orasanu G, Plutzky J (2009) The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53:S35-S42
29. Bengmark S (2006) Impact of nutrition on ageing and disease. Curr Opin Clin Nutr Metab Care 9:2-7
30. Brownlee M (2007) Preventing kidney cell suicide. Nat Med 13:1284-1285
31. Yamagishi S, Matsui T (2010) Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev 3:101-108
32. Partyka A, Lukaszewicz E, Niżański W (2012) Lipid peroxidation and antioxidant enzymes activity in avian semen. Anim Reprod Sci. doi: 10.1016/j.anireprosci.2012.07.007
33. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790
34. Orr AW, Hahn C, Blackman BR, Schwartz MA (2008) p21-activated kinase signaling regulates oxidant-dependent NF-kappa B activation by flow. Circ Res 103:671-679
35. Barazzoni R, Zanetti M, Cappellari GG, Semolic A, Boschelle M, Codarin E, Pirulli A, Cattin L, Guarnieri G (2012) Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. Diabetologia 55:773-782
36. Zheng Z, Chen H, Li J, Li T, Zheng B, Zheng Y, Jin H, He Y, Gu Q, Xu X (2012) Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin. Diabetes 61:217-228
37. Kang R, Tang D, Lotze MT, Zeh HJ 3rd (2011) RAGE regulates autophagy and apoptosis following oxidative injury. Autophagy 7:442-444
38. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Klöting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Häring HU, Schleicher E, Nawroth PP (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792-2808
39. Cheng M, Gao HQ, Xu L, Li BY, Zhang H, Li XH (2007) Cardioprotective effects of grape seed proanthocyanidins extracts in streptozocin induced diabetic rats. J Cardiovasc Pharmacol 50:503-509
40. Williams ME, Bolton WK, Khalifah RG, Degenhardt TP, Schotzinger RJ, McGill JB (2007) Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol 27:605-614
41. An Y, Zhang Y, Li C, Qian Q, He W, Wang T (2011) Inhibitory effects of flavonoids from Abelmoschus manihot flowers on triglyceride accumulation in 3T3-L1 adipocytes. Fitoterapia 82:595-600